- Home
- / Shorla Oncology
Shorla Oncology
Total Funding
$43.3 M
Shorla Oncology Summary
Company Summary
- Overview
- Shorla Oncology (also known as Shorla Pharma) is a pharmaceutical company that develops cancer treatment solutions. It offers nelarabine injections for treating T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL).
- Type
- Private
- Status
- Active
- Founded
- 2018
- HQ
- Clonmel, IE | view all locations
- Website
- https://shorlaoncology.com/
- Cybersecurity rating
Table of Contents
Key People
Maurice Clancy, Vice President of Research and Development
Denis Delaney, Director of Research and Development
Orlaith Ryan, Co-Founder, CTO & Executive Director, Ireland
LocationsView all
2 locations detected
Clonmel, TA HQ
Ireland
Questum Acceleration Center, Ballingarrane Science & Technology Park
Cambridge, MA
United States
245 Main Street, 2nd floor